Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-027067
Filing Date
2014-04-10
Accepted
2014-04-10 19:17:32
Documents
1
Period of Report
2014-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4915
  Complete submission text file 0001209191-14-027067.txt   6239
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609
Business Address
Tunnicliffe Jonathan (Reporting) CIK: 0001597990 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 14758392